Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of
VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor
Home ยป
Study reports lasting immune response in convalescent COVID-19 patients
Using different types of assays, researchers found both cellular and humoral immune responses for up to eight months in coronavirus
12 High-End Moisturizers That Are Actually Worth the Splurge
Being an Allure editor most definitely has its perks: The most obvious one being the chance to try just about